image description

Tag: Albert Roy

2024 Lupus Research Alliance Gala Raises Millions to Improve Lives of People with Lupus

The 2024 Lupus Research Alliance (LRA) Breaking Through Gala raised nearly $3 million for lupus research, bringing the hope for a world free of lupus closer with every dollar.  Emceed by two-time Emmy Award-Winning host and bestselling author Tamron Hall, the evening included a commanding performance by GRAMMY® nominated genre-blending singer/songwriter and activist Halsey. In […] Read More

New York Jets Take On Lupus at 2024 Season Kickoff Luncheon

The Lupus Research Alliance (LRA) is proud to have helped launch this year’s football season at the New York Jets Annual Kickoff Luncheon yesterday. In addition to introducing the 2024 team roster, the event spotlighted the worthwhile causes supported by the New York Jets.  With the support of more than 500 passionate fans, the luncheon […] Read More

Statement from the Lupus Research Alliance Related to Halsey’s Lupus Announcement

The Lupus Research Alliance (LRA) expresses deep appreciation to the renowned singer and songwriter Halsey on sharing two powerful Instagram posts (June 4 and June 5) about their diagnosis of systemic lupus erythematosus (SLE) and a rare T-cell lymphoproliferative disorder. Halsey released yesterday on Instagram a new song, The End, expressing their challenges and tagging the Lupus Research […] Read More

A Message from LRA President Introducing LRA’s celebration of Lupus Awareness Month

Dear Friends, Lupus Awareness Month officially starts today, and with so many advancements, never has there been a time for more optimism. We are delighted to begin May following a productive first-anniversary meeting of the Lupus Accelerating Breakthroughs Consortium (Lupus ABC) where people with lupus partner with representatives from the FDA, industry, and researchers on […] Read More

Lupus Research Alliance Gala Raises $2 Million for Research to Transform Treatment

This year’s Lupus Research Alliance (LRA) Breaking Through Gala raised $2 million for lupus research and brought the hope of tremendous progress that’s improving lupus treatment while driving to a cure.  The annual celebration began with a powerhouse performance and moving tribute to lupus warriors by multi-talented pianist, composer, producer, and Sony Music recording artist […] Read More

New York Jets Go on the Offense to Tackle Lupus at 2023 Season Kickoff Luncheon

The Lupus Research Alliance (LRA) is proud and grateful to have helped launch the upcoming football season at the New York Jets Annual Kickoff Luncheon. In addition to introducing super-star Aaron Rodgers and the 2023 team roster, the event spotlighted the worthwhile causes supported by the New York Jets including lupus research. With the backing […] Read More

Data at ACR 2022 Shows Lupus Research Alliance Peer Education Program Increases Intentions to Join Clinical Trials Among Diverse Patient Population

NEW YORK, NY–November 8, 2022 — The Lupus Research Alliance and clinical researchaffiliate Lupus Therapeutics will present data at ACR Convergence 2022 showing that the pilot peer education program Patient Advocates for Lupus Studies (PALS), increased knowledge, perception, and intentions among people with Systemic Lupus Erythematosus (SLE) to participate in clinical trials. These study results […] Read More

Long-time Supporter LADA Donates $150,000 to LRA-Funded Research

August 29, 2022 Big thanks go to the Lupus and Allied Diseases Association, Inc. (LADA) for their donation of $150,000 to support research funded by the Lupus Research Alliance given at their 22nd Annual Lupus Charity Golf Classic at Shenendoah Golf Course at Turning Stone in upstate New York. LADA President & CEO Kathleen A. […] Read More

LRA Brings Encouraging News from European Rheumatology Meeting

June 2, 2022 The Lupus Research Alliance (LRA) and its clinical trial arm Lupus Therapeutics congratulate Bristol Myers Squibb (BMS) on new positive results presented at the European Alliance of Associations for Rheumatology (EULAR) 2022 Congress from a Phase 2 trial of its investigational biologic deucravacitinib for the treatment of systemic lupus erythematosus (SLE). Deucravacitinib […] Read More